Evgenia Dobrinskikh
Concepts (409)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucin-5B | 12 | 2026 | 234 | 2.790 |
Why?
| | Idiopathic Pulmonary Fibrosis | 15 | 2026 | 691 | 2.220 |
Why?
| | Lung | 14 | 2026 | 4109 | 1.510 |
Why?
| | Acetaminophen | 4 | 2025 | 264 | 1.460 |
Why?
| | Lung Injury | 4 | 2026 | 237 | 1.420 |
Why?
| | Hernias, Diaphragmatic, Congenital | 3 | 2020 | 219 | 1.420 |
Why?
| | Fetus | 5 | 2025 | 803 | 1.100 |
Why?
| | Bleomycin | 6 | 2026 | 253 | 1.100 |
Why?
| | Liver | 9 | 2026 | 1887 | 0.900 |
Why?
| | Endocytosis | 4 | 2014 | 168 | 0.800 |
Why?
| | Respiratory Mucosa | 3 | 2025 | 322 | 0.720 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 2 | 2013 | 9 | 0.710 |
Why?
| | Podocytes | 6 | 2019 | 80 | 0.710 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2021 | 269 | 0.710 |
Why?
| | Kidney Tubules, Proximal | 2 | 2013 | 130 | 0.660 |
Why?
| | Animals | 50 | 2026 | 38058 | 0.660 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2020 | 44 | 0.630 |
Why?
| | Therapeutic Occlusion | 1 | 2020 | 3 | 0.630 |
Why?
| | Fetal Therapies | 1 | 2020 | 47 | 0.590 |
Why?
| | Organogenesis | 1 | 2019 | 65 | 0.560 |
Why?
| | Glycolysis | 4 | 2021 | 339 | 0.560 |
Why?
| | Serum Albumin | 3 | 2019 | 147 | 0.550 |
Why?
| | Nerve Tissue Proteins | 2 | 2013 | 592 | 0.540 |
Why?
| | Tracheal Stenosis | 1 | 2018 | 39 | 0.530 |
Why?
| | Liver Cirrhosis | 3 | 2025 | 288 | 0.530 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.510 |
Why?
| | Disease Models, Animal | 13 | 2026 | 4557 | 0.480 |
Why?
| | Diet, Western | 4 | 2025 | 86 | 0.470 |
Why?
| | Fluorescein-5-isothiocyanate | 3 | 2014 | 36 | 0.460 |
Why?
| | Mice | 25 | 2026 | 18339 | 0.450 |
Why?
| | Gene Expression Regulation | 4 | 2021 | 2608 | 0.440 |
Why?
| | Endoplasmic Reticulum Stress | 3 | 2026 | 120 | 0.430 |
Why?
| | Fetal Growth Retardation | 3 | 2025 | 587 | 0.430 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 210 | 0.430 |
Why?
| | Caveolae | 1 | 2014 | 16 | 0.420 |
Why?
| | Cytochrome P-450 CYP2E1 | 3 | 2025 | 30 | 0.400 |
Why?
| | Rabbits | 3 | 2020 | 648 | 0.400 |
Why?
| | Bile Acids and Salts | 4 | 2025 | 164 | 0.370 |
Why?
| | Receptors, G-Protein-Coupled | 4 | 2022 | 233 | 0.360 |
Why?
| | Cysts | 2 | 2022 | 111 | 0.310 |
Why?
| | Pregnancy | 12 | 2025 | 7190 | 0.310 |
Why?
| | Kidney | 4 | 2019 | 1495 | 0.300 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2023 | 266 | 0.300 |
Why?
| | Optical Imaging | 2 | 2021 | 64 | 0.290 |
Why?
| | Diabetic Nephropathies | 3 | 2017 | 318 | 0.290 |
Why?
| | Pulmonary Surfactants | 2 | 2020 | 102 | 0.280 |
Why?
| | Signal Transduction | 12 | 2026 | 5226 | 0.280 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 3 | 2025 | 209 | 0.280 |
Why?
| | Lysosomes | 3 | 2014 | 128 | 0.280 |
Why?
| | Hepacivirus | 3 | 2015 | 243 | 0.270 |
Why?
| | Hypoxia | 2 | 2025 | 1199 | 0.260 |
Why?
| | Trachea | 2 | 2020 | 261 | 0.260 |
Why?
| | Placental Insufficiency | 2 | 2025 | 125 | 0.260 |
Why?
| | Extracellular Matrix | 2 | 2021 | 553 | 0.250 |
Why?
| | SOXC Transcription Factors | 1 | 2026 | 9 | 0.250 |
Why?
| | Receptors, Fc | 2 | 2019 | 55 | 0.240 |
Why?
| | Bronchioles | 1 | 2026 | 29 | 0.240 |
Why?
| | Muscle, Striated | 1 | 2026 | 12 | 0.240 |
Why?
| | Vero Cells | 1 | 2006 | 84 | 0.230 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2026 | 79 | 0.230 |
Why?
| | Pseudopodia | 1 | 2006 | 27 | 0.230 |
Why?
| | Sheep | 5 | 2026 | 880 | 0.230 |
Why?
| | Muscle Fibers, Slow-Twitch | 1 | 2025 | 23 | 0.230 |
Why?
| | Vascular Remodeling | 2 | 2025 | 205 | 0.230 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 676 | 0.230 |
Why?
| | Female | 26 | 2026 | 78271 | 0.220 |
Why?
| | Microvessels | 1 | 2026 | 99 | 0.220 |
Why?
| | Biliary Atresia | 1 | 2026 | 158 | 0.220 |
Why?
| | Capillaries | 1 | 2025 | 124 | 0.210 |
Why?
| | Fetal Hypoxia | 1 | 2025 | 56 | 0.210 |
Why?
| | Humans | 42 | 2026 | 144759 | 0.210 |
Why?
| | Glucagon | 1 | 2025 | 112 | 0.210 |
Why?
| | Microglia | 2 | 2024 | 268 | 0.210 |
Why?
| | Chorionic Villi | 1 | 2024 | 25 | 0.210 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2025 | 181 | 0.200 |
Why?
| | Metabolomics | 2 | 2020 | 727 | 0.200 |
Why?
| | Umbilical Arteries | 1 | 2024 | 52 | 0.200 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2024 | 67 | 0.190 |
Why?
| | Macrophages, Alveolar | 1 | 2026 | 368 | 0.190 |
Why?
| | Eukaryotic Initiation Factor-2B | 1 | 2023 | 6 | 0.190 |
Why?
| | Microscopy, Fluorescence | 2 | 2016 | 416 | 0.190 |
Why?
| | Microtubules | 1 | 2006 | 286 | 0.190 |
Why?
| | Cell Line | 5 | 2017 | 2882 | 0.190 |
Why?
| | Fibrosis | 6 | 2023 | 548 | 0.190 |
Why?
| | Sirtuin 3 | 1 | 2023 | 60 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2025 | 1980 | 0.190 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.190 |
Why?
| | Endotoxemia | 1 | 2023 | 87 | 0.180 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2024 | 319 | 0.180 |
Why?
| | Leukocytes | 1 | 2024 | 295 | 0.180 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2019 | 198 | 0.180 |
Why?
| | Male | 20 | 2026 | 72315 | 0.180 |
Why?
| | Mice, Knockout | 7 | 2026 | 3121 | 0.180 |
Why?
| | Receptors, Lysophosphatidic Acid | 1 | 2022 | 40 | 0.180 |
Why?
| | Primates | 4 | 2024 | 132 | 0.180 |
Why?
| | Kidney Diseases | 2 | 2017 | 427 | 0.180 |
Why?
| | Genetic Predisposition to Disease | 5 | 2026 | 2363 | 0.180 |
Why?
| | Gain of Function Mutation | 2 | 2018 | 36 | 0.180 |
Why?
| | Ductus Arteriosus, Patent | 1 | 2022 | 50 | 0.170 |
Why?
| | Assisted Circulation | 1 | 2021 | 26 | 0.170 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2022 | 93 | 0.170 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 113 | 0.170 |
Why?
| | Bone Marrow | 1 | 2023 | 304 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.170 |
Why?
| | Cell Movement | 1 | 2006 | 965 | 0.170 |
Why?
| | Rats | 6 | 2019 | 5597 | 0.170 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2022 | 142 | 0.170 |
Why?
| | Amino Acids | 1 | 2025 | 521 | 0.170 |
Why?
| | Phenotype | 3 | 2024 | 3162 | 0.160 |
Why?
| | Phosphates | 2 | 2013 | 180 | 0.160 |
Why?
| | Placenta | 2 | 2025 | 780 | 0.160 |
Why?
| | Kidney Tubules | 2 | 2019 | 117 | 0.160 |
Why?
| | Epithelium | 1 | 2021 | 314 | 0.160 |
Why?
| | Aortic Diseases | 1 | 2021 | 124 | 0.160 |
Why?
| | Hepatitis C | 2 | 2015 | 254 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 1 | 2023 | 420 | 0.150 |
Why?
| | Cholic Acids | 2 | 2017 | 13 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 151 | 0.150 |
Why?
| | NF-kappa B | 1 | 2023 | 661 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 220 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2024 | 365 | 0.150 |
Why?
| | Molecular Imaging | 1 | 2019 | 55 | 0.150 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 143 | 0.150 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2019 | 34 | 0.140 |
Why?
| | Mice, Inbred C57BL | 8 | 2025 | 5992 | 0.140 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 72 | 0.140 |
Why?
| | Mucociliary Clearance | 1 | 2018 | 43 | 0.140 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 276 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2021 | 226 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 338 | 0.140 |
Why?
| | Muscle, Skeletal | 2 | 2026 | 1795 | 0.140 |
Why?
| | Rats, Sprague-Dawley | 3 | 2014 | 2527 | 0.140 |
Why?
| | Biomarkers | 3 | 2021 | 4271 | 0.140 |
Why?
| | Organ Size | 1 | 2019 | 463 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 675 | 0.130 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 4 | 0.130 |
Why?
| | Telomere | 1 | 2021 | 288 | 0.130 |
Why?
| | Lipid Metabolism | 2 | 2022 | 527 | 0.130 |
Why?
| | Relaxin | 1 | 2017 | 18 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 202 | 0.130 |
Why?
| | 5'-Nucleotidase | 1 | 2017 | 49 | 0.130 |
Why?
| | Alzheimer Disease | 1 | 2024 | 621 | 0.130 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 48 | 0.130 |
Why?
| | Glucuronidase | 1 | 2017 | 25 | 0.130 |
Why?
| | Gangliosides | 1 | 2017 | 23 | 0.130 |
Why?
| | Membrane Microdomains | 1 | 2017 | 34 | 0.130 |
Why?
| | Salmonella enterica | 1 | 2017 | 59 | 0.130 |
Why?
| | Arrhythmias, Cardiac | 1 | 2020 | 361 | 0.130 |
Why?
| | Insulin | 2 | 2025 | 2507 | 0.130 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.120 |
Why?
| | Protein Transport | 2 | 2019 | 441 | 0.120 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2020 | 359 | 0.120 |
Why?
| | Proteolysis | 2 | 2014 | 173 | 0.120 |
Why?
| | Cell Polarity | 2 | 2014 | 137 | 0.120 |
Why?
| | Myocardium | 2 | 2020 | 939 | 0.120 |
Why?
| | Immunity, Maternally-Acquired | 1 | 2015 | 19 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 529 | 0.120 |
Why?
| | Adenosine | 1 | 2017 | 255 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2021 | 567 | 0.110 |
Why?
| | Promoter Regions, Genetic | 4 | 2026 | 1257 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.110 |
Why?
| | Claudin-1 | 1 | 2015 | 15 | 0.110 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2017 | 381 | 0.110 |
Why?
| | Renal Insufficiency | 1 | 2017 | 168 | 0.110 |
Why?
| | Obesity | 3 | 2019 | 3077 | 0.110 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 69 | 0.110 |
Why?
| | Clathrin | 2 | 2014 | 26 | 0.110 |
Why?
| | Autocrine Communication | 1 | 2014 | 38 | 0.110 |
Why?
| | Epithelial Cells | 3 | 2018 | 1125 | 0.110 |
Why?
| | Tight Junctions | 1 | 2015 | 81 | 0.110 |
Why?
| | Mitochondria | 4 | 2025 | 984 | 0.110 |
Why?
| | Immunoglobulin G | 1 | 2019 | 893 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 371 | 0.100 |
Why?
| | Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 12 | 0.100 |
Why?
| | Transcytosis | 1 | 2014 | 7 | 0.100 |
Why?
| | Microvilli | 2 | 2012 | 75 | 0.100 |
Why?
| | Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.100 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 19 | 0.100 |
Why?
| | Colitis | 2 | 2013 | 280 | 0.100 |
Why?
| | Albumins | 1 | 2014 | 118 | 0.100 |
Why?
| | Oxidative Stress | 4 | 2025 | 1339 | 0.100 |
Why?
| | Aging | 3 | 2024 | 1966 | 0.100 |
Why?
| | Creatine Kinase | 1 | 2013 | 72 | 0.100 |
Why?
| | Exosomes | 1 | 2014 | 104 | 0.100 |
Why?
| | Immunity, Innate | 4 | 2023 | 846 | 0.100 |
Why?
| | Heart | 1 | 2017 | 636 | 0.100 |
Why?
| | Fibroblasts | 3 | 2025 | 1034 | 0.100 |
Why?
| | Creatine | 1 | 2013 | 63 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 102 | 0.100 |
Why?
| | Interferons | 1 | 2014 | 188 | 0.100 |
Why?
| | Vesicular Transport Proteins | 1 | 2014 | 86 | 0.100 |
Why?
| | Didelphis | 1 | 2013 | 3 | 0.100 |
Why?
| | Transcriptome | 1 | 2020 | 1045 | 0.100 |
Why?
| | Trophoblasts | 1 | 2015 | 216 | 0.100 |
Why?
| | Interferon-gamma | 2 | 2013 | 784 | 0.090 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2012 | 8 | 0.090 |
Why?
| | Brain | 2 | 2024 | 2933 | 0.090 |
Why?
| | Enterocytes | 1 | 2012 | 16 | 0.090 |
Why?
| | Cell Hypoxia | 1 | 2013 | 247 | 0.090 |
Why?
| | Sodium-Hydrogen Exchangers | 1 | 2012 | 22 | 0.090 |
Why?
| | Quantitative Trait Loci | 2 | 2026 | 374 | 0.090 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2019 | 653 | 0.090 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 467 | 0.090 |
Why?
| | Lung Diseases, Interstitial | 1 | 2018 | 660 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 309 | 0.090 |
Why?
| | Virus Replication | 1 | 2014 | 529 | 0.090 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2013 | 178 | 0.090 |
Why?
| | Green Fluorescent Proteins | 1 | 2013 | 405 | 0.080 |
Why?
| | RNA Interference | 1 | 2013 | 476 | 0.080 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2015 | 428 | 0.080 |
Why?
| | Phosphorus, Dietary | 1 | 2010 | 4 | 0.080 |
Why?
| | RNA, Messenger | 4 | 2021 | 2832 | 0.080 |
Why?
| | Kidney Cortex | 1 | 2010 | 27 | 0.080 |
Why?
| | Hepatocytes | 2 | 2026 | 223 | 0.080 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 635 | 0.080 |
Why?
| | Kinetics | 1 | 2014 | 1627 | 0.080 |
Why?
| | Glomerular Filtration Rate | 1 | 2014 | 760 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2012 | 344 | 0.080 |
Why?
| | Galectins | 1 | 2010 | 27 | 0.080 |
Why?
| | Kupffer Cells | 1 | 2010 | 53 | 0.080 |
Why?
| | Inflammation | 4 | 2026 | 2878 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 94 | 0.080 |
Why?
| | Arthritis, Rheumatoid | 1 | 2018 | 1169 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 442 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3863 | 0.070 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 68 | 0.070 |
Why?
| | Endosomes | 1 | 2010 | 140 | 0.070 |
Why?
| | Cell Membrane | 1 | 2013 | 706 | 0.070 |
Why?
| | STAT3 Transcription Factor | 2 | 2025 | 207 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 4154 | 0.070 |
Why?
| | Hypertension | 1 | 2017 | 1263 | 0.070 |
Why?
| | Longevity | 2 | 2022 | 173 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2014 | 869 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2019 | 2182 | 0.070 |
Why?
| | Middle Aged | 7 | 2026 | 35875 | 0.070 |
Why?
| | Heart Failure | 1 | 2021 | 2323 | 0.070 |
Why?
| | Cohort Studies | 3 | 2024 | 5960 | 0.060 |
Why?
| | X-Box Binding Protein 1 | 1 | 2026 | 16 | 0.060 |
Why?
| | Uteroglobin | 1 | 2026 | 30 | 0.060 |
Why?
| | Diacetyl | 1 | 2006 | 7 | 0.060 |
Why?
| | Nocodazole | 1 | 2006 | 17 | 0.060 |
Why?
| | Thiazolidines | 1 | 2006 | 13 | 0.060 |
Why?
| | Haemophilus Infections | 1 | 2026 | 45 | 0.060 |
Why?
| | Aged | 5 | 2026 | 25913 | 0.060 |
Why?
| | Haemophilus influenzae | 1 | 2026 | 67 | 0.060 |
Why?
| | Platelet Factor 4 | 1 | 2025 | 36 | 0.060 |
Why?
| | Receptors, Glucagon | 1 | 2025 | 26 | 0.050 |
Why?
| | Disease Progression | 2 | 2026 | 2847 | 0.050 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 95 | 0.050 |
Why?
| | Gluconeogenesis | 1 | 2025 | 83 | 0.050 |
Why?
| | Neovascularization, Physiologic | 1 | 2026 | 194 | 0.050 |
Why?
| | Platelet Activation | 1 | 2025 | 104 | 0.050 |
Why?
| | Blood Glucose | 2 | 2025 | 2327 | 0.050 |
Why?
| | Allyl Compounds | 1 | 2023 | 26 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2006 | 279 | 0.050 |
Why?
| | Biphenyl Compounds | 1 | 2023 | 68 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 22 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2026 | 902 | 0.050 |
Why?
| | Ultrasonography, Doppler | 1 | 2024 | 126 | 0.050 |
Why?
| | NAD | 1 | 2023 | 81 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2026 | 557 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2026 | 442 | 0.050 |
Why?
| | Desmoplakins | 1 | 2022 | 24 | 0.050 |
Why?
| | Phenols | 1 | 2023 | 114 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2024 | 206 | 0.050 |
Why?
| | Immunophenotyping | 1 | 2024 | 322 | 0.050 |
Why?
| | PQQ Cofactor | 1 | 2022 | 5 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2026 | 6429 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2017 | 1370 | 0.050 |
Why?
| | PPAR alpha | 1 | 2022 | 54 | 0.050 |
Why?
| | HEK293 Cells | 2 | 2017 | 744 | 0.050 |
Why?
| | Pulmonary Alveoli | 1 | 2025 | 383 | 0.040 |
Why?
| | Gestational Age | 1 | 2025 | 975 | 0.040 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.040 |
Why?
| | ADAMTS4 Protein | 1 | 2021 | 16 | 0.040 |
Why?
| | Long Term Adverse Effects | 1 | 2021 | 13 | 0.040 |
Why?
| | Tyrphostins | 1 | 2021 | 18 | 0.040 |
Why?
| | Amphiregulin | 1 | 2021 | 27 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1982 | 0.040 |
Why?
| | Fetal Development | 1 | 2024 | 299 | 0.040 |
Why?
| | Blood Platelets | 1 | 2025 | 400 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2023 | 262 | 0.040 |
Why?
| | Keratin-5 | 1 | 2021 | 48 | 0.040 |
Why?
| | Membrane Glycoproteins | 1 | 2024 | 496 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2025 | 780 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 197 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 1000 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 380 | 0.040 |
Why?
| | Cilia | 1 | 2022 | 173 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2021 | 388 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2023 | 416 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2022 | 261 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 226 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2014 | 1173 | 0.040 |
Why?
| | Positron-Emission Tomography | 1 | 2021 | 323 | 0.040 |
Why?
| | Premature Birth | 1 | 2024 | 380 | 0.040 |
Why?
| | Keratin-15 | 1 | 2019 | 17 | 0.040 |
Why?
| | Quinazolines | 1 | 2021 | 266 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2022 | 636 | 0.040 |
Why?
| | Maternal Exposure | 1 | 2021 | 213 | 0.040 |
Why?
| | Colloids | 1 | 2019 | 61 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 197 | 0.040 |
Why?
| | Receptors, Leukotriene | 1 | 2019 | 13 | 0.040 |
Why?
| | Antioxidants | 1 | 2023 | 549 | 0.040 |
Why?
| | Liver Transplantation | 1 | 2026 | 823 | 0.040 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2019 | 36 | 0.040 |
Why?
| | Expectorants | 1 | 2018 | 23 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2021 | 630 | 0.040 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 279 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2022 | 358 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 178 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2018 | 45 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2026 | 920 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 427 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2020 | 521 | 0.030 |
Why?
| | Kidney Glomerulus | 1 | 2019 | 128 | 0.030 |
Why?
| | Ureteral Obstruction | 1 | 2019 | 62 | 0.030 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 71 | 0.030 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 157 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2021 | 627 | 0.030 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 12 | 0.030 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 21 | 0.030 |
Why?
| | Nucleotidases | 1 | 2017 | 6 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2022 | 576 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1490 | 0.030 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 5 | 0.030 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 187 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 779 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2021 | 1716 | 0.030 |
Why?
| | Heart Function Tests | 1 | 2017 | 59 | 0.030 |
Why?
| | Bacterial Load | 1 | 2017 | 67 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 681 | 0.030 |
Why?
| | Urinalysis | 1 | 2017 | 80 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 456 | 0.030 |
Why?
| | Gelatin | 1 | 2017 | 56 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2017 | 157 | 0.030 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 29 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 299 | 0.030 |
Why?
| | Pancreas | 1 | 2019 | 341 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 88 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 190 | 0.030 |
Why?
| | RNA | 1 | 2022 | 940 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1075 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 127 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1463 | 0.030 |
Why?
| | Salmonella typhimurium | 1 | 2017 | 190 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 406 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 520 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2027 | 0.030 |
Why?
| | Tissue Scaffolds | 1 | 2017 | 223 | 0.030 |
Why?
| | HeLa Cells | 1 | 2017 | 650 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2017 | 380 | 0.030 |
Why?
| | Denys-Drash Syndrome | 1 | 2014 | 4 | 0.030 |
Why?
| | WT1 Proteins | 1 | 2014 | 12 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 381 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 509 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 11 | 0.030 |
Why?
| | Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 20 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 662 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2015 | 336 | 0.030 |
Why?
| | Dextran Sulfate | 1 | 2013 | 92 | 0.030 |
Why?
| | Superoxide Dismutase | 1 | 2015 | 301 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1833 | 0.020 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2015 | 193 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2013 | 151 | 0.020 |
Why?
| | Dextrans | 1 | 2013 | 86 | 0.020 |
Why?
| | Permeability | 1 | 2013 | 168 | 0.020 |
Why?
| | Adult | 3 | 2024 | 40449 | 0.020 |
Why?
| | Transcription Factors | 1 | 2021 | 1741 | 0.020 |
Why?
| | Tissue Engineering | 1 | 2017 | 442 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 383 | 0.020 |
Why?
| | Interleukins | 1 | 2014 | 248 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 370 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2017 | 556 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 336 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 512 | 0.020 |
Why?
| | Caco-2 Cells | 1 | 2012 | 79 | 0.020 |
Why?
| | Neurons | 1 | 2021 | 1640 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 905 | 0.020 |
Why?
| | Infant | 1 | 2026 | 10034 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2012 | 156 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 594 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1187 | 0.020 |
Why?
| | Child, Preschool | 1 | 2026 | 11787 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1306 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2014 | 437 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1769 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2013 | 1054 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 862 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 80 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 139 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 459 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 202 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3540 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 737 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 673 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 573 | 0.020 |
Why?
| | Monocytes | 1 | 2010 | 538 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10779 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2012 | 1166 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2061 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2024 | 17066 | 0.010 |
Why?
| | Immunotherapy | 1 | 2010 | 653 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1129 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2583 | 0.010 |
Why?
| | Macrophages | 1 | 2010 | 1511 | 0.010 |
Why?
| | Child | 1 | 2022 | 22633 | 0.010 |
Why?
|
|
Dobrinskikh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|